Dr Marcin Ufnal from Medical University of Warsaw, Poland will join the Porto Microbiota 2018 Congress which will be held in October 28-30, 2018, at Porto, Portugal and will talk about "The effect of gut bacterial metabolites on cardiovascular risk" during the congress.
Dr Ufnal will highlight: "Gut bacteria-produced compounds enter the bloodstream and affect the circulatory system. For example, trimethylamine N-oxide (TMAO), a gut bacteria metabolite of L-carnitine and choline, has recently emerged as a new diagnostic marker and mediator of increased cardiovascular risk. However, the mechanism is not clear.Recently we have found that high sodium intake and treatment with ACE-inhibitors affect blood concentration of TMAO in rats. This suggests that plasma level of gut bacterial metabolites may correlate with interventions modifying cardiovascular risk."
For more information: www.microbiota-site.com